125,276 Shares in Cardinal Health, Inc. $CAH Acquired by Beck Bode LLC

Key Points

• Beck Bode LLC invested approximately $17.26 million in Cardinal Health, acquiring 125,276 shares which now represents 3.2% of its portfolio and makes Cardinal Health its 9th largest holding.
• Cardinal Health reported $2.08 EPS for the last quarter, exceeding expectations, with a revenue of $60.16 billion, slightly below the consensus estimate of $60.91 billion.
• The company will pay a quarterly dividend of $0.5107 per share on October 15th, yielding approximately 1.4% annually.

Beck Bode LLC bought a new position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 125,276 shares of the company's stock, valued at approximately $17,259,000. Cardinal Health makes up about 3.2% of Beck Bode LLC's portfolio, making the stock its 9th largest position. Beck Bode LLC owned approximately 0.05% of Cardinal Health at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Eisler Capital Management Ltd. bought a new stake in shares of Cardinal Health in the first quarter valued at approximately $279,000. B. Metzler seel. Sohn & Co. AG increased its holdings in shares of Cardinal Health by 112.8% in the 1st quarter. B. Metzler seel. Sohn & Co. AG now owns 24,646 shares of the company's stock worth $3,395,000 after buying an additional 13,065 shares during the last quarter. CreativeOne Wealth LLC increased its holdings in shares of Cardinal Health by 64.6% in the 1st quarter. CreativeOne Wealth LLC now owns 6,644 shares of the company's stock worth $915,000 after buying an additional 2,608 shares during the last quarter. FORA Capital LLC bought a new position in shares of Cardinal Health during the 1st quarter valued at $988,000. Finally, Virtus Advisers LLC purchased a new stake in Cardinal Health during the 1st quarter valued at $163,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Cardinal Health

In other news, insider Jessica L. Mayer sold 38,078 shares of the company's stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the transaction, the insider owned 48,457 shares in the company, valued at $7,211,370.74. This represents a 44.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Michelle D. Greene sold 13,500 shares of the company's stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the transaction, the insider owned 14,976 shares in the company, valued at approximately $2,228,728.32. This trade represents a 47.41% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 271,676 shares of company stock valued at $40,489,525. 0.09% of the stock is currently owned by corporate insiders.

Cardinal Health Trading Up 0.4%

CAH traded up $0.57 during trading hours on Tuesday, hitting $149.35. The company's stock had a trading volume of 536,821 shares, compared to its average volume of 2,418,572. The business's 50-day moving average price is $157.10 and its 200-day moving average price is $146.46. Cardinal Health, Inc. has a 12 month low of $106.54 and a 12 month high of $168.44. The stock has a market cap of $35.66 billion, a price-to-earnings ratio of 23.17, a P/E/G ratio of 1.26 and a beta of 0.73.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping the consensus estimate of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The company had revenue of $60.16 billion for the quarter, compared to analysts' expectations of $60.91 billion. During the same quarter in the previous year, the business posted $1.84 earnings per share. Cardinal Health's quarterly revenue was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be issued a $0.5107 dividend. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.4%. Cardinal Health's dividend payout ratio is presently 31.63%.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on CAH shares. Jefferies Financial Group set a $150.00 price target on shares of Cardinal Health in a research report on Tuesday, August 12th. Argus set a $189.00 price target on shares of Cardinal Health in a research report on Friday, August 22nd. Morgan Stanley reissued an "overweight" rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Leerink Partners reduced their price objective on shares of Cardinal Health from $188.00 to $186.00 and set an "outperform" rating for the company in a research note on Tuesday, August 12th. Finally, Wells Fargo & Company reiterated an "overweight" rating and issued a $185.00 price target (up from $183.00) on shares of Cardinal Health in a research note on Wednesday, August 13th. Twelve research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, Cardinal Health currently has a consensus rating of "Moderate Buy" and a consensus target price of $165.93.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.